Trexquant Investment’s Centessa Pharmaceuticals CNTA Stock Holding History

Trexquant Investment’s Portfolio CNTA Stock Details CNTA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-390,951	Closed	-$15.5M	–	1937
2026 Q1	$15.5M	Buy	390,951 +244,428	+167%	+$6.25M	0.11%	223
2025 Q4	$3.66M	Buy	146,523 +84,213	+135%	+$2.13M	0.03%	743
2025 Q3	$1.51M	Sell	62,310 -89,042	-59%	-$1.58M	0.02%	1015
2025 Q2	$1.99M	Sell	151,352 -112,642	-43%	-$1.43M	0.02%	886
2025 Q1	$3.8M	Buy	263,994 +2,810	+1%	+$46K	0.04%	611
2024 Q4	$4.37M	Buy	261,184 +90,233	+53%	+$1.49M	0.05%	573
2024 Q3	$2.73M	Buy	170,951 +127,203	+291%	+$1.56M	0.03%	690
2024 Q2	$395K	Sell	43,748 -52,783	-55%	-$501K	0.01%	1308
2024 Q1	$1.09M	Buy	96,531 +82,177	+573%	+$778K	0.02%	888
2023 Q4	$114K	Buy	+14,354	New	+$96.2K	﹤0.01%	1363

Trexquant Investment's CNTA Position: Q2 2026 in Review

Trexquant Investment sold out of Centessa Pharmaceuticals (CNTA) in Q2 2026, closing a stake of 390,951 shares — an estimated $15.5M sold.

Trexquant Investment first reported a position in CNTA in Q4 2023 and held it in 10 quarters. The position peaked at $15.5M in Q1 2026. 0 funds tracked by Wall St. Rank hold CNTA as of Q2 2026.

Trexquant Investment reported no remaining Centessa Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
Trexquant Investment sold 390,951 Centessa Pharmaceuticals shares in Q2 2026, an estimated $15.5M.
Trexquant Investment first reported a position in Centessa Pharmaceuticals in Q4 2023 and held it in 10 quarters.
Trexquant Investment's Centessa Pharmaceuticals position peaked at $15.5M in Q1 2026.
0 funds tracked by Wall St. Rank held Centessa Pharmaceuticals as of Q2 2026.

Based on Trexquant Investment's 13F filing for Q2 2026, filed 14 Aug 2026.